[1]
|
Suzer, O., Bozkurt, A.K., Suzer, A., Aykac, Z. and Barlas, A. (1996) The comparison of the ?notropic effects of levosimendan and amrinone after ischemia in ?solated perfused guinea pig hearts. Turk Gogus Kalp Dama, 1, 5-8.
|
[2]
|
Tritapepe, L., De Santis, V., Vitale, D., Guarracino, F., Pellegrini, F., Pietropaoli, P., et al. (2009) Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. British Journal of Anaesthesia, 102, 198-204. doi:10.1093/bja/aen367
|
[3]
|
Maltais, S., Ladouceur, M. and Cartier, R. (2011) The influence of a low ejection fraction on long-term survival in systematic off-pump coronary artery bypass surgery. British Journal of Anaesthesia, 39, 122-127.
doi:10.1016/j.ejcts.2010.12.022
|
[4]
|
Lahtinen, P., Pitk?nen, O., P?l?nen, P., Turpeinen, A., Kiviniemi, V. and Uusaro, A. (2011) Levosimendan reduces heart failure after cardiac surgery: A prospective, randomized, placebo-controlled trial. Critical Care Medicine, 39, 2263-2270.
doi:10.1097/CCM.0b013e3182227b97
|
[5]
|
Malliotakis, P., Xenikakis, T., Linardakis, M. and Hassoulas, J. (2007) Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: A case series. The Hellenic Journal of Cardiology, 48, 80-88.
|
[6]
|
Tasouli, A., Papadopoulos, K., Antoniou, T., Kriaras, I., Stavridis, G., Degiannis, D., et al. (2007) Efficacy and safety of perioperative infusion of levosimendan in pa- tients with compromised cardiac function undergoing open-heart surgery: Importance of early use. European Journal Cardio—Thoracic Surgery, 32, 629-633.
doi:10.1016/j.ejcts.2007.07.010
|
[7]
|
Kolseth, S.M., Nordhaug, D.O., Stenseth, R., Sellevold, O., Kirkeby-Garstad, I. and Wahba, A. (2009) Prophy- lactic treatment with levosimendan: A retrospective matched- control study of patients with reduced left ventricular function. European Journal Cardio—Thoracic Surgery, 36, 1024-1030. doi:10.1016/j.ejcts.2009.05.001
|
[8]
|
Maisel, W.H., Rawn, J.D. and Stevenson, W.G. (2001) Atrial fibrillation after cardiac surgery. Annals of Internal Medicine, 18, 1061-1073.
|
[9]
|
Tek, M., Cavusoglu, Y., Demirustu, C., Birdane, A., Unalir, A., Gorenek, B., et al. (2010) Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure. Archives of the Turkish Society of Cardiology, 38, 334-340.
|
[10]
|
Maharaj, R. and Metaxa, V. (2011) Levosimendan and mortality after coronary revascularisation: A meta-analysis of randomised controlled trials. Critical Care, 15, R140. doi:10.1186/cc10263
|